Esperion Announces Positive Top-Line Results from Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Tablet in Patients with Hypercholesterolemia and Type 2 Diabetes August 29, 2019 - NASDAQ Companies 0 » View More News for August 29, 2019